Cargando…

Functional Nanomedicines for Targeted Therapy of Bladder Cancer

Bladder cancer is one of most common malignant urinary tract tumor types with high incidence worldwide. In general, transurethral resection of non-muscle-invasive bladder cancer followed by intravesical instillation of chemotherapy is the standard treatment approach to minimize recurrence and delay...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Chao, Liu, Heng, Fan, Yanpeng, He, Jiahao, Li, Fuqiu, Wang, Jin, Hou, Yuchuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635105/ https://www.ncbi.nlm.nih.gov/pubmed/34867408 http://dx.doi.org/10.3389/fphar.2021.778973

Ejemplares similares

Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
por: He, Lili, et al.
Publicado: (2016)

Ferroptosis-Inducing Nanomedicine for Cancer Therapy
por: Wang, Yang, et al.
Publicado: (2021)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
por: Yang, Fan, et al.
Publicado: (2023)

Application Perspectives of Nanomedicine in Cancer Treatment
por: Hou, Shanshan, et al.
Publicado: (2022)

Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
por: Ding, Lei, et al.
Publicado: (2022)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
por: Hu, Ping Ping, et al.
Publicado: (2022)

Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)

Pharmacologic therapies of ARDS: From natural herb to nanomedicine
por: Meng, Linlin, et al.
Publicado: (2022)

Editorial: Women in nanomedicine
por: Chuah, Lay-Hong, et al.
Publicado: (2023)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

Editorial: Advances and Challenges in Nanomedicine
por: Hua, Susan, et al.
Publicado: (2018)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
por: Li, Xue, et al.
Publicado: (2022)

Two-Dimensional Nanosheet-Based Photonic Nanomedicine for Combined Gene and Photothermal Therapy
por: Kim, Na Yoon, et al.
Publicado: (2020)

Nanomedicine in Cancer Targeting and Therapy
por: Palamà, Ilaria Elena, et al.
Publicado: (2022)

Ferroptosis: A new therapeutic target for bladder cancer
por: Zeng, Fan, et al.
Publicado: (2022)

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy
por: Zhang, Jinlan, et al.
Publicado: (2023)

A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy
por: Yang, Yang, et al.
Publicado: (2022)

Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy
por: Xu, Xiaoqiu, et al.
Publicado: (2022)

Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
por: Tian, Tian
Publicado: (2022)

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
por: Zhang, Bo, et al.
Publicado: (2017)

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines
por: Marepally, Srujan, et al.
Publicado: (2022)

Nanomedicine in cancer therapy
por: Fan, Dahua, et al.
Publicado: (2023)

Advanced Peptide Nanomedicines for Bladder Cancer Theranostics
por: Zeng, Sheng, et al.
Publicado: (2022)

The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles
por: Frigaard, Julie, et al.
Publicado: (2022)

Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?
por: Jiang, Yichuan, et al.
Publicado: (2023)

Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32
por: Wu, Kang, et al.
Publicado: (2022)

Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine
por: Wei, Wumei, et al.
Publicado: (2021)

Layered Double Hydroxide Nanomaterials Encapsulating Angelica gigas Nakai Extract for Potential Anticancer Nanomedicine
por: Kim, Hyoung-Jun, et al.
Publicado: (2018)

Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
por: Wu, Ping-Hsiu, et al.
Publicado: (2019)

Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy
por: Wang, Xiaowei, et al.
Publicado: (2020)

Nanomedicine targets iron metabolism for cancer therapy
por: Lin, Liangru, et al.
Publicado: (2022)

Traditional Tibetan Medicine in Cancer Therapy by Targeting Apoptosis Pathways
por: Tang, Ce, et al.
Publicado: (2020)

Nanomedicine for Combination Therapy of Cancer
por: He, Chunbai, et al.
Publicado: (2015)

Sulforaphane and bladder cancer: a potential novel antitumor compound
por: Zuo, Mingshun, et al.
Publicado: (2023)

NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
por: Xie, Xiang, et al.
Publicado: (2021)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018)

Cancer Nanomedicine: From Targeted Delivery to Combination Therapy
por: Xu, Xiaoyang, et al.
Publicado: (2015)

Hyaluronic Acid-Coated Nanomedicine for Targeted Cancer Therapy
por: Kim, Kibeom, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q2d933e1qqbspqejlln1m37ugk